Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer

NCT07088731 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Cervical Carcinoma

Interventions

DRUG: Sintilimab
RADIATION: Concurrent chemo-radiotherapy

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences